Home › US companies › Align Technology

Align Technology

ALGN · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Insider buys (12 months)

Insider sales (12 months)

$1.5M

8-K reports (12 months)

Tracked investors holding

At a glance

Align Technology reported 2025 revenue of $4.03B, up 0.9% from $4B in 2024. Over 4 years since 2021 ($3.95B), that is growth of about 0.5% a year. Operating margin was 13.5%, down from 24.7% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 1 insider reported 0 open-market purchases and 1 sale ($1.5M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $1.5M by EVP, CHIEF FINANCIAL OFFICER John Morici on Feb 20, 2026.

Align Technology filed 12 current reports (Form 8-K) in the last 12 months, most often for officer or director change (4), results of operations (4), regulation fd disclosure (2) and shareholder vote results (1). The latest officer or director change was reported on Oct 28, 2026.

2 of the 20 investors tracked here held Align Technology at the last quarter end, worth $14.8M combined. It is the largest weight for Bridgewater Associates (0.1% of its portfolio), followed by ARK Investment Management (0%). Added: Bridgewater Associates. Reduced: ARK Investment Management.